Divis Laboratories Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 23 May 2026.

Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 6722, up 1.07% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 24018.3. The Sensex is at 76839.15, down 0.23%. Divis Laboratories Ltd has gained around 14.91% in last one month.

Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has gained around 10.1% in last one month and is currently quoting at 23568.95, up 2.16% on the day. The volume in the stock stood at 1.33 lakh shares today, compared to the daily average of 2.86 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 6779, up 1.68% on the day. Divis Laboratories Ltd is up 9.34% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.

The PE of the stock is 68.65 based on TTM earnings ending December 25.

Powered by Capital Market - Live News

Divis Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at Rs 5824.5, down 1.39% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 1.28% on the day, quoting at 22388.45. The Sensex is at 72170.86, down 1.32%.Divis Laboratories Ltd has eased around 7.78% in last one month.Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has eased around 4.37% in last one month and is currently quoting at 22011.6, down 1.5% on the day. The volume in the stock stood at 3.7 lakh shares today, compared to the daily average of 2.86 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 5847.5, down 1.5% on the day. Divis Laboratories Ltd jumped 1.07% in last one year as compared to a 3.71% slide in NIFTY and a 1.21% spurt in the Nifty Pharma index.

The PE of the stock is 60.95 based on TTM earnings ending December 25.

Net profit of Divi's Laboratories declined 1.02% to Rs 583.00 crore in the quarter ended December 2025 as against Rs 589.00 crore during the previous quarter ended December 2024. Sales rose 12.29% to Rs 2604.00 crore in the quarter ended December 2025 as against Rs 2319.00 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News